Enovix Corporation has released a supplemental FAQ to clarify details regarding its warrant dividend distribution. The document addresses potential limitations for shareholders with Enovix stock in margin accounts and the timing of share purchases related to warrant eligibility. The company emphasizes the impact of brokerage practices, like securities lending in margin accounts, on receiving exercisable warrants. Shareholders are encouraged to review the supplement and contact brokers for specific account inquiries.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.